Do Bartonella infections cause agitation, panic disorder, and treatment-resistant depression?

MedGenMed Medscape General Medicine

Volumn 9, Issue 3, 2007, Pages

  Schaller, James L ^a,b   Burkland, Glenn A ^c   Langhoff, P J ^d  

^a Professional Medical Services of Naples   (United States)

^b Professional Medical Services of Naples   (United States)

^c TEMPLE UNIVERSITY   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFDINIR; CEFUROXIME; CLONAZEPAM; ESCITALOPRAM; LITHIUM CARBONATE; QUETIAPINE; RIFABUTIN; RIFAMPICIN; S ADENOSYLMETHIONINE; SERTRALINE; VALPROIC ACID;

ADULT; AGITATION; ANTIBODY TITER; ARTICLE; BACTERIUM DETECTION; BARTONELLA HENSELAE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; INFECTION RISK; LABORATORY TEST; MALE; NONHUMAN; PANIC; PSYCHOLOGICAL RATING SCALE; RECOMMENDED DRUG DOSE; REMISSION; RICKETTSIOSIS; RISK ASSESSMENT; RISK FACTOR; SEDATION; SIDE EFFECT; TREATMENT DURATION; RESTLESSNESS; TREATMENT FAILURE;

ADULT; BARTONELLA INFECTIONS; DEPRESSION; FEMALE; HUMANS; MALE; PANIC DISORDER; PSYCHOMOTOR AGITATION; TREATMENT FAILURE;

EID: 34548774649     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Massei F, Gori L, Macchia P, Maggiore G. The expanded spectrum of bartonellosis in children. Infect Dis Clin North Am. 2005;19:691-711. Abstract
2. Murakami K, Tsukahara M, Tsuneoka H, et al. Cat scratch disease: analysis of 130 seropositive cases. J Infect Chemother. 2002;8:349-352. Abstract
3. Jardine C, Waldner C, Wobeser G, Leighton FA. Effect of experimental ectoparasite control on Bartonella infections in wild Richardson's ground squirrels. J. Wildl Dis. 2006;42:750-758. Abstract
4. Sreter-Lancz Z, Tomyai K, Szell Z, Sreter T, Marialigeti K. Bartonella infections in fleas (Siphonaptera: Pulicidae) and lack of Bartonella in ticks (Acari: Ixodidae) from Hungary. Folia Parasitol (Praha). 2006;53:313-316. Abstract
5. Easterbrook JD, Kaplan JB, Vanasco NB, et al. A survey of zoonotic pathogens carried by Norway rats in Baltimore, Maryland, USA. Epidemiol Infect. 2007 Jan 15:1-8 [Epub ahead of print].
6. Izri A, Depaquit J, Parola P. [Phlebotomine sandflies and transmission of disease agents around the Mediterranean basin] [Article in French]. Med Trop (Mars). 2006;66:429-435. Abstract
7. Vincent JM, Demers DM, Bass JW. Infectious exanthems and unusual infections. Adolesc Med. 2000;11:327-358. Abstract
8. Vincent JM, Demers DM, Bass JW. Infectious exanthems and unusual infections. Adolesc Med. 2000;11:327-358. Abstract
9. Massei F, Messina F, Talini I, et al. Widening of the clinical spectrum of Bartonella henselae infection as recognized through serodiagnostics. Eur J Pediatr. 2000;159:416-419. Abstract
10. Mikolajczyk MG, O'Reilly KL. Clinical disease in kittens inoculated with a pathogenic strain of Bartonella henselae. Am J Vet Res. 2000;61:375-379. Abstract
11. Reeves WK, Szumlas DE, Moriarity JR, et al. Louse-borne bacterial pathogens in lice (Phthiraptera) of rodents and cattle from Egypt. J Parasitol. 2006;92:313-318. Abstract
12. Reeves WK, Nelder MP, Korecki JA. Bartonella and Rickettsia in fleas and lice from mammals in South Carolina, U.S.A. J Vector Ecol. 2005;30:310-315. Abstract
13. McGill S, Rajs J, Hjelm E, Lindquist O, Friman G. A study on forensic samples of Bartonella spp antibodies in Swedish intravenous heroin addicts. APMIS. 2003;111:507-513. Abstract
14. Catscratch disease. EMedicine. Available at: http://www.emedicine.com/ emerg/topic84.htm Accessed September 6, 2007.
15. Jackson LA, Spach DH. Emergence of Bartonella quintana infection among homeless persons. Emerg Infect Dis. 1996;2:141-144. Abstract
16. Heller R, Kubina M, Mariet P, et al. Bartonella alsatica sp. nov., a new Bartonella species isolated from the blood of wild rabbits. Int J Syst Bacteriol. 1999;49(Pt 1):283-288. Abstract
17. Maurin M, Raoult D. Bartonella infections: diagnostic and management issues. Curr Opin Infect Dis. 1998; 11: 189-193. Abstract
18. Marie JL, Fournier PE, Rolain JM, Briolant S, Davoust B, Raoult D. Molecular detection of Bartonella quintana, B. elizabethae, B. koehlerae, B. doshiae, B. taylorii, and Rickettsia felis in rodent fleas collected in Kabul, Afghanistan. Am J Trop Med Hyg. 2006;74:436-439. Abstract
19. Boulouis HJ, Chang CC, Henn JB, Kasten RW, Chomel BB. Factors associated with the rapid emergence of zoonotic Bartonella infections. Vet Res. 2005;36:383-410. Abstract
20. Vukelic D, Benic B, Bazinovic D, et al. An unusual outcome in a child with hepatosplenic cat-scratch disease. Wien Klin Wochenschr. 2006;118:615-618. Abstract
21. Lab Corp test name: Bartonella Antibody Profile. Test Number 163162. Available at: http:/www.labcorp.com/dos/index.html Accessed September 6, 2007.
22. Quest Diagnostics test name: Bartonella Species Antibody (IGG, IGM) with Reflex to Titers. Code 34251. Available at: http://cas2.questdiagnostics.com/scripts/webdos.wls?MGWLPN= QDCWS0209&wlapp=DOS&OrderCode=34251&SITE=26&SearchString= B%2A&tmradio=title Accessed September 6, 2007.
23. Focus Technologies. Bartonella Antibody Panel, IFA (Serum). Code 4020. And Bartonella DNA, PCR. Code 47000. Available at: http:/www.focusdx.com/ focus/1-reference_laboratory/search_frame.asp?f=2 Accessed September 6, 2007.
24. Ziemssen F, Bartz-Schmidt KU, Gelisken F. Secondary unilateral glaucoma and neuroretinitis: atypical manifestation of cat-scratch disease. Jpn J Opthalmol. 2006;50:177-179. Abstract
25. Ben-Ami R, Ephros M, Avidor B, et al. Cat-scratch disease in elderly patients. Clin Infect Dis. 2005;41:969-974. Abstract
26. Reynolds MG, Holman RC, Curns AT, O'Reilly M, McQuiston JH, Steiner CA: Epidemiology of cat-scratch disease hospitalizations among children in the United States. Pediatr Infect Dis J. 2005;24:700-704. Abstract
27. Ridder GJ, Boedeker CC, Technau-Ihling K, Sander A. Cat-scratch disease: Otolaryngologic manifestations and management. Otolary Head Neck Surg. 2005;132:353-358. Abstract
28. Lamps LW, Scott MA. Cat-scratch disease: historic, clinical, and pathologic perspectives. Am J Clin Pathol. 2004;121(Suppl):S71-80. Abstract
29. Metzkor-Cotter E, Kletter Y, Avidor B, et al. Long-term serological analysis and clinical follow-up of patients with cat scratch disease. Clin Infect Dis. 2003;37:1149-1154.
30. Murakami K, Tsukahara M, Tsuneoka H, et al. Cat scratch disease: analysis of 130 seropositive cases. J Infect Chemother. 2002;8:34
31. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore). 2005;84:162-173. Abstract
32. Pedersen BK. Sudden cardiac death in Swedish orienteers - a mystery solved? Scand J Med Sci Sports. 2001;11:259.
33. Meininger GR, Nadasdy T, Hruban RH, Bollinger RC, Baughman KL, Hare JM. Chronic active myocarditis following acute Bartonella henselae infection (cat scratch disease). Am J Surg Pathol. 2001;25:1211-1214. Abstract
34. Wesslen L, Ehrenborg C, Holmberg M, et al. Subacute Bartonella infection in Swedish orienteers succumbing to sudden unexpected cardiac death or having malignant arrhythmias. Scand J Infect Dis. 2001;33:429-438. Abstract
35. McGill S, Wesslen L, Hjelm E, Holmberg M, Rolf C, Friman G. Serological and epidemiological analysis of the prevalence of Bartonella spp. antibodies in Swedish elite orienteers 1992-93. Scand J Infect Dis. 2001;33:423-428. Abstract
36. Pedersen, BK. [Bartonella bacterium is suspected as the cause of sudden death among Swedish cross-country runners.] [Article in Danish]. Ugeskr Laeger. 2001;163:2951.
37. Posfay Barbe K, Jaeggi E, Ninet B, et al. Bartonella quintana endocarditis in a child. N Engl J Med. 2000;342:1841-1842. Abstract
38. Gerber JE, Johnson JE, Scott MA, Madhusudhan KT. Fatal meningitis and encephalitis due to Bartonella henselae bacteria. J Forensi Sci. 2002;47:640-644. Abstract
39. [No authors listed]. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 1-1998. An 11-year-old boy with a seizure. N Engl J Med. 1998;338:112-119. Erratum in: N Engl J Med 1998;338:483. Comment in: N Engl J Med. 1998;338:1549-1550.
40. Wheeler SW, Wolf SM, Steinberg EA. Cat-scratch encephalopathy. Neurology. 1997;49:876-878. Comment in: Neurology. 1998;51:1239.
41. Chan L, Reilly KM, Snyder HS. An unusual presentation of cat scratch encephalitis. J Emerg Med. 1995;13:769-772. Abstract
42. Centers for Disease Control and Prevention (CDC). Encephalitis associated with cat scratch disease - Broward and Palm Beach Count MMWR Morb Mortal Wkly Rep. 1994;43:909, 915-916.
43. Baker J, Ruiz-Rodriguez R, Whitfeld M, Heon V, Berger TG. Bacillary angiomatosis: a treatable cause of acute psychiatric symptoms i immunodeficiency virus infection. J Clin Psychiatry. 1995;56:161-166. Abstract
44. Marra CM. Neurologic complications of Bartonella henselae infection. Curr Opin Neurol. 1995;8:164-169. Abstract
45. Harvey RA, Misselbeck WJ, Uphold RE. Cat-scratch disease: an unusual cause of combative behavior. Am J Emerg Med. 1991;9:52-5
46. Angibaud G, Balague JP, Lafontan JF. [Bartonella hensalae encephalopathy] [Article in French]. Presse Med. 2005;34:297-298. Abstract
47. Singhal AB, Newstein MC, Budzik R, et al. Diffusion-weighted magnetic resonance imaging abnormalities in Bartonella encephalopathy. J Neuroimaging 2003;13:79-82. Abstract
48. Touyama M, Uezu K, Nakamoto A, et al. [A case of cat scratch disease with encephalopathy] [Article in Japanese]. Kansenshogaku Zasshi 2002;76:113-117. Abstract
49. 3y E, Tylewska-Wierzbanowska S. Presence of Bartonella spp. in various human populations. Pol J Microbiol. 2007;56:33-38. Abstract.
50. Borboli S, Afshari NA, Watkins L, Foster CS. Presumed oculoglandular syndrome from Bartonella quintana. Ocul Immunol Inflamm. 2007;15:41-43. Abstract.
51. Rolain JM, Arnoux D, Parzy D, Sampol J, Raoult D. Experimental infection of human erythrocytes from alcoholic patients with Bartonella quitana. Ann NY Acad Sci. 2003;990:605-611. Abstract
52. Breathnach AS, Hoare JM, Eykyn SJ. Culture-negative endocarditis: contribution of Bartonella infections. Heart. 1997;77:474-476. Abstract
53. Comer JA, Flynn C, Regnery RL, Vlahov D, Childs JE. Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md. Arch Intern Med. 1996;156:2491-2495. Abstract
54. Zimmerman M, Coryell W. The validity of a self-report questionnaire for diagnosing major depressive disorder. Arch Gen Psychiatry. 1988;45:738-740. Abstract
55. Zimmerman M, Coryell W. The Inventory to Diagnose Depression (IDD): a self-report scale to diagnose major depressive disorder. J Consult Clin Psychol. 1987;55:55-59. Abstract
56. Zimmerman M, Coryell W, Corenthal C, Wilson S. A self-report scale to diagnose major depressive disorder. Arch Gen Psychiatry. 1986;43:1076-1081. Abstract
57. Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006;20:444-458. Abstract
58. Kabacoff RI, Segal DL, Hersen M, Van Hasselt VB. Psychometric properties and diagnostic utility of the Beck Anxiety Inventory and the State-Trait Anxiety Inventory with older adult psychiatric outpatients. J Anxiety Disord. 1997;11:33-47. Abstract
59. Creamer M, Foran J, Bell R. The Beck Anxiety Inventory in a non-clinical sample. Behav Res Ther. 1995;33:477-485. Abstract
60. Goren JL, Stoll AL, Damico KE, Sarmiento IA, Cohen BM. Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans. Pharmacotherapy. 2004;24:1501-1507. Abstract
61. Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. Am J Clin Nutr. 2002;76:1172S-1176S. Abstract
62. Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr. 2002;76:1158S-1161S. Abstract
63. Di Rocco A, Rogers JD, Brown R, Werner P, Bottiglieri T. S-adenosyl-methionine improves depression in patients with Parkinson's disease in an open-label clinical trial. Mov Disord. 2000;15:1225-1229. Abstract
64. Williams AL, Girard C, Jui D, Sabina A, Katz DL. S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. Clin Invest Med. 2005;28:132-139. Abstract
65. Alpert JE, Papakostas G, Mischoulon D, et al. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine. J Clin Psychopharmacol. 2004;24:661-664. Abstract
66. Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology. 1995;45:219-223. Abstract
67. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol. 1997;17:208-221. Abstract
68. Mehock JR, Greene CE, Gherardini FC, Hahn TW, Krause DC. Bartonella henselae invasion of feline erythrocytes in vitro. Infect Immun. 1998;17:208-221. Abstract
69. Kordick DL, Breitschwerdt EB. Intraerythrocytic presence of Bartonella henselae. J Clin Microbiol. 1995;33:1655-1656. Abstract
70. Mandle T, Einsele H, Schaller M, et al. Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B. henselae. Blood. 2005;106:1215-1222. Abstract
71. Medkova Z. [Bartonelloses] [Article in Czech]. Klin Mikrobiol Infekc Lek. 2004;10:207-213. Abstract
72. Schmid MC, Schulein R, Dehio M, Denecker G, Carena I, Dehio C. The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells. Mol Microbiol. 2004;52:81-92. Abstract
73. Rolain JM, Locatelli C, Chabanne L, Davoust B, Raoult D. Prevalence of Bartonella clarridgeiae and Bartonella henselae in domestic cats from France and detection of the organisms in erythrocytes by immunofluorescence. Clin Diagn Lab Immunol. 2004;11:423-425. Abstract
74. Seubert A, Hiestand R, de la Cruz F, Dehio C. A bacterial conjugation machinery recruited for pathogenesis. Mol Microbiol. 2003;49:1253-1266. Abstract
75. Rolain JM, Maurin M, Mallet MN, Parzy D, Raoult D. Culture and antibiotic susceptibility of Bartonella quintana in human erythrocytes. Antimicrob Agents Chemother. 2003;47:614-619. Abstract
76. Schulein R, Dehio C. The VirB/VirD4 type IV secretion system of Bartonella is essential for establishing intraerythrocytic infection. Mol Microbiol 2002;46:1053-1067. Abstract
77. Rolain JM, Foucault C, Guieu R, La Scola B, Brouqui P, Raoult D. Bartonella quintana in human erythrocytes. Lancet. 2002;360:226-228. Abstract
78. Rolain JM, La Scola B, Liang Z, Davoust B, Raoult D. Immunofluorescent detection of intraerythrocytic Bartonella henselae in naturally infected cats. J Clin Microbiol. 2001;39:2978-2980. Abstract
79. Koesling J, Aebischer T, Falch C, Schulein R, Dehio C. Cutting edge: antibody-mediated cessation of hemotropic infection by the intraerythrocytic mouse pathogen Bartonella grahamil. J Immunol. 2001;167:11-14. Abstract
80. Schulein R, Seubert A, Gille C, et al. Invasion and persistent intracellular colonization of erythrocytes. A unique parasitic strategy of the emerging pathogen Bartonella. J Exp Med. 2001;193:1077-1086. Abstract
81. Guptill L, Wu CC, Glickman L, Turek J, Slater L, HogenEsch H. Extracellular Bartonella henselae and artifactual intraerythrocytic pseudoinclusions in experimentally infected cats. Vet Microbiol. 2000;76:283-290. Abstract
82. Bass JW, Vincent JM, Person DA. The expanding spectrum of Bartonella infections: II. Cat-scratch disease. Pediatr Infect Dis J. 1997;16:163-179. Abstract
83. Kordick DL, Breitschwerdt EB. Intra-erythrocytic presence of Bartonella henselae. J Clin Microbiol. 1995;33:1655-1656. Abstract
84. Puligheddu M, Giagheddu A, Genugu F, Giagheddu M, Marrosu F. Epilepsia partialis continua in cat scratch disease. Seizure. 2004;13:191-195. Erratum in: Seizure. 2006;15:357.
85. Rocha JL, Pellegrino LN, Riella LV, Martins LT. Acute hemiplegia associated with cat-scratch disease. Braz J Infect Dis. 2004;8:263-266. Abstract
86. Conrad DA. Treatment of cat-scratch disease. Curr Opin Pediatr. 2001;13:56-59. Abstract